TerminatedPhase 2/3

Treatment of Peri-calcification Edema in Neurocysticercosis (NCC)

Stopped: Low recruitment

Peru4 participantsStarted 2015-12-04

Plain-language summary

Three-arm open, randomized comparative study of acetazolamide, dexamethasone, or no additional treatment to evaluate decrease in peri-calcification edema in neurocysticercosis

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Calcified NCC * Perilesional edema on CT or MRI * Normal lab values Exclusion Criteria: * Viable neurocysticercosis * Status epilepticus * Symptomatic intracranial hypertension * Tuberculosis * More than 7 days after seizure * Pregnancy

What they're measuring

Decrease in Volume of Perilesional Edema Between Baseline and Day 4

Timeframe: Baseline to Day 4

Trial details

NCT IDNCT02945527

SponsorUniversidad Peruana Cayetano Heredia

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-12

View on ClinicalTrials.gov More Neurocysticercosis trials